Qiagen NV (QIA):企業の財務・戦略的SWOT分析

◆英語タイトル:Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15273
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Qiagen NV (QIA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Qiagen NV (Qiagen) is a provider of molecular testing solutions. The company’s sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers its products through subsidiaries and a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.

Qiagen NV Key Recent Developments

Mar 08,2019 Qiagen parthers with Tecan to improve tuberculosis test
Feb 19,2019 Qiagen, Ares Genetics partner on tests for antibiotic-resistant pathogens
Feb 04,2019 QIAGEN Informatics Solutions Chosen to Support Genomics Englands Bold Five Million Genomes in Five Years Project

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Qiagen NV – Key Facts
Qiagen NV – Key Employees
Qiagen NV – Key Employee Biographies
Qiagen NV – Major Products and Services
Qiagen NV – History
Qiagen NV – Company Statement
Qiagen NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Qiagen NV – Business Description
Product Category: Consumables and Related Revenues
Overview
Performance
Product Category: Instrumentation
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific and Rest of World
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
R&D Overview
Qiagen NV – SWOT Analysis
SWOT Analysis – Overview
Qiagen NV – Strengths
Qiagen NV – Weaknesses
Qiagen NV – Opportunities
Qiagen NV – Threats
Qiagen NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019
Qiagen NV, Medical Equipment, Deals By Type, 2013 to YTD 2019
Qiagen NV, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 08, 2019: Qiagen partners with Tecan to improve tuberculosis test
Mar 08, 2019: Qiagen parthers with Tecan to improve tuberculosis test
Feb 19, 2019: Qiagen, Ares Genetics partner on tests for antibiotic-resistant pathogens
Feb 04, 2019: QIAGEN Informatics Solutions Chosen to Support Genomics Englands Bold Five Million Genomes in Five Years Project
Feb 04, 2019: QIAGEN informatics solutions chosen to support Genomics England’s bold five million genomes in five years project
Feb 04, 2019: QIAGEN announces results for fourth quarter and full-year 2018
Jan 16, 2019: QIAGEN receives first companion diagnostic approval in Japan
Jan 07, 2019: QIAGEN to Develop QuantiFERON®-TB Access as a New Test for Low-Resource, High-Burden Regions in Global Fight Against TB
Jan 07, 2019: QIAGEN unveils plans for next-generation digital PCR systems
Jan 07, 2019: QIAGEN launches QIAcube Connect – next-generation automation for sample processing in research labs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Qiagen NV, Key Facts
Qiagen NV, Key Employees
Qiagen NV, Key Employee Biographies
Qiagen NV, Major Products and Services
Qiagen NV, History
Qiagen NV, Subsidiaries
Qiagen NV, Joint Venture
Qiagen NV, Key Competitors
Qiagen NV, Ratios based on current share price
Qiagen NV, Annual Ratios
Qiagen NV, Annual Ratios (Cont...1)
Qiagen NV, Annual Ratios (Cont...2)
Qiagen NV, Interim Ratios
Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019
Qiagen NV, Medical Equipment, Deals By Type, 2013 to YTD 2019
Qiagen NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Qiagen NV, Performance Chart (2014 - 2018)
Qiagen NV, Ratio Charts
Qiagen NV, Medical Equipment, Deals By Year, 2013 to YTD 2019
Qiagen NV, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Qiagen NV (QIA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Shenhua Energy Co Ltd:企業のM&A・事業提携・投資動向
    China Shenhua Energy Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Shenhua Energy Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Coal India Ltd:戦略・SWOT・企業財務分析
    Coal India Ltd - Strategy, SWOT and Corporate Finance Report Summary Coal India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sentien Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sentien Biotechnologies Inc (Sentien) is a clinical stage biotechnology company that develops novel delivery approaches to cell therapy. The company’s lead product SBI-101 is used for the treatment of patients with severe acute kidney injury (AKI). Its Sentinel is designed to enable controll …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrol …
  • Polpharma SA-製薬・医療分野:企業M&A・提携分析
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • ALS Ltd (ALQ):石油・ガス:M&Aディール及び事業提携情報
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides offers chemical and laboratory services, technical testing and inspection servic …
  • Halt Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It o …
  • Sartorius AG (SRT):医療機器:M&Aディール及び事業提携情報
    Summary Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for …
  • Reed’s, Inc.:企業の戦略・SWOT・財務情報
    Reed's, Inc. - Strategy, SWOT and Corporate Finance Report Summary Reed's, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Spire Inc (SR):企業の財務・戦略的SWOT分析
    Spire Inc (SR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Manchester United Plc:企業の戦略・SWOT・財務情報
    Manchester United Plc - Strategy, SWOT and Corporate Finance Report Summary Manchester United Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Smith Micro Software Inc (SMSI):企業の財務・戦略的SWOT分析
    Summary Smith Micro Software Inc (Smith Micro) is a software development company that develops productivity and graphic software products for professional artists and general consumers. The company offers products such as NetWise, QuickLink, consumer and CommSuite products. Its NetWise products comp …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. Nippon Chemiphar offers diagnostic products, such as IgE NC, a diagnostic kit t …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務情報
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • OGD2 Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary OGD2 Pharma SAS (OGD2 Pharma) is an independent pre-clinical stage biotechnology company that researches, develops and commercializes cancer immunotherapies targeting the O-acetylated form of the GD2 ganglioside (OAcGD2). The company pipeline product portfolio includes OGD201, a humanized mo …
  • Novita Healthcare Ltd (NHL):企業の財務・戦略的SWOT分析
    Novita Healthcare Ltd (NHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Yomeishu Seizo Co Ltd (2540):企業の財務・戦略的SWOT分析
    Yomeishu Seizo Co Ltd (2540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AMVIG Holdings Ltd.:企業の戦略・SWOT・財務情報
    AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary AMVIG Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Belk Inc:戦略・SWOT・企業財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆